Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.36 - $17.1 $90,842 - $4.32 Million
252,340 Added 8297.93%
255,381 $71,000
Q2 2022

Aug 12, 2022

SELL
$1.14 - $3.48 $9,228 - $28,170
-8,095 Reduced 72.69%
3,041 $3,000
Q1 2022

May 12, 2022

BUY
$3.07 - $5.55 $6,818 - $12,326
2,221 Added 24.91%
11,136 $38,000
Q4 2021

Feb 10, 2022

BUY
$5.12 - $14.5 $768 - $2,175
150 Added 1.71%
8,915 $46,000
Q3 2021

Nov 09, 2021

BUY
$12.9 - $16.83 $1,638 - $2,137
127 Added 1.47%
8,765 $127,000
Q2 2021

Aug 11, 2021

BUY
$13.28 - $18.45 $114,712 - $159,371
8,638 New
8,638 $147,000

About HELIUS MEDICAL TECHNOLOGIES, INC.


  • Ticker HSDT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,197,200
  • Market Cap $12.7M
  • Description
  • Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...
More about HSDT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.